Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirus

Journal of Visualized Experiments

Volumn , Issue 63, 2012, Pages

  Hanley, Patrick J ^a   Lam, Sharon ^a   Shpall, Elizabeth J ^b   Bollard, Catherine M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cord blood; Cytotoxic T lymphocytes (CTL); Immunology; Issue 63; Medicine; Na ve T cells; Stem cell transplantation; Virus

Indexed keywords

EPITOPE;

ADENOVIRUS; ADENOVIRUS INFECTION; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FETUS BLOOD; HUMAN; IMMUNOLOGY; MONONUCLEAR CELL; VIROLOGY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; EPSTEIN-BARR VIRUS INFECTIONS; FETAL BLOOD; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84863731327     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3627     Document Type: Article

References (18)

1. Kennedy-Nasser, A.A., et al. Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen. Biol. Blood Marrow Transplant. 14 (11), 1245 (2008).
2. Hanley, P.J., et al. Improving clinical outcomes using adoptively transferred immune cells from umbilical cord blood. Cytotherapy. 12 (6), 713 (2010).
3. Szabolcs, P. & Cairo, M.S. Unrelated umbilical cord blood transplantation and immune reconstitution. Semin. Hematol. 47 (1), 22 (2010).
4. Canto, E., Rodriguez-Sanchez, J.L., & Vidal, S. Distinctive response of naive lymphocytes from cord blood to primary activation via TCR. J. Leukoc. Biol. 74 (6), 998 (2003).
5. Leen, A.M., et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat. Med. 12 (10), 1160 (2006).
6. Riddell, S.R., et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257 (5067), 238 (1992).
7. O'Reilly, R.J., et al. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunol. Res. 38 (1-3), 237 (2007).
8. Peggs, K.S., et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 362 (9393), 1375 (2003).
9. Sili, U., et al. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy. J. Immunother. 26 (3), 241 (2003).
10. Bollard, C.M., et al. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma. Cytotherapy. 13 (5), 518 (2011).
11. Hanley, P.J., et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes. Blood. 114 (9), 1958 (2009).
12. Hanley, P.J., et al. Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation. Cytotherapy., (2011).
13. Gerdemann, U., et al. Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant. J. Vis. Exp. (51), e2736, DOI: 10.3791/2736 (2011).
14. Mori, T. & Kato, J. Cytomegalovirus infection/disease after hematopoietic stem cell transplantation. Int. J. Hematol. 91 (4), 588 (2010).
15. Einsele, H., et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 99 (11), 3916 (2002).
16. Bao, L., et al. Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 14 (10), 1156 (2008).
17. Shpall, E.J., Bollard, C.M., & Brunstein, C. Novel cord blood transplant therapies. Biol. Blood Marrow Transplant. 17 (1 Suppl.), S39-S45 (2011).
18. Vera, J.F., et al. Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J. Immunother. 33 (3), 305 (2010).